对于痴呆症和轻度认知障碍的过度运动
Alexandra Voinescu1, Themis Papaioannou1, Karin Petrini1,2
1Department of Psychology, University of Bath, Bath, UK.
The Cochrane database of systematic reviews
|September 25, 2024
概括
运动游戏可能会提高痴呆症和轻度认知障碍 (MCI) 患者的认知功能,但证据非常不确定. 与通常的护理相比,这种技术驱动的干预显示出潜力,而不是特定的体力活动.
科学领域:
- 老年学和康复医学 老年学和康复医学
- 神经科学和认知健康
- 人与计算机的交互和数字健康
背景情况:
- 痴呆症和轻度认知障碍 (MCI) 在老年人中显著增加了残疾和依赖.
- 目前对这些疾病的治疗选择有限.
- 使用技术进行体力炼和认知任务的混合体育游戏 (exergaming) 是一种潜在的干预手段.
研究的目的:
- 评估游戏干预对身体和认知结果的影响.
- 评估痴呆症和MCI患者日常生活活动 (ADL) 的变化.
- 综合来自随机对照试验 (RCT) 关于exergaming有效性和安全性的证据.
主要方法:
- 对多个数据库 (例如,MEDLINE,Embase,PsycINFO) 进行了系统的搜索.
- 包括的RCT涉及患有痴呆症或MCI的参与者通过虚拟现实 (VR) 或交互式技术从事中等到强烈的体力活动.
- 数据提取,偏差风险评估 (RoB 2) 和证据确定性评估 (GRADE) 是由两个评审人独立进行的.
主要成果:
- 包括11项研究 (2014-2023年) 涉及536名参与者 (308名MCI,228名痴呆症).
- 与对照组相比,过度游戏可能会改善痴呆症和MCI的整体认知功能,尽管证据非常不确定.
- 关于身体功能,ADL和不良影响的证据仍然非常不确定,因为偏差和有限数据的高风险.
结论:
- 对游戏对痴呆和MCI的身体,认知和日常生活结果的影响的整体证据的确定性非常低.
- 只有在与非活动对照组相比较时,才观察到潜在的认知益处,而不是像特定炼这样的积极替代品.
- 没有监督的家庭游戏的安全性仍然是未知的,因为所有包括的研究都涉及受控的,受监督的环境.
相关概念视频
01:30Cognitive Development During Adulthood
66
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
66
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
01:30Dementia
102
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
102
01:26Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
107
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
107
01:24Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235